The Impact of Breathing Hypoxic Gas and Oxygen on Pulmonary Hemodynamics in Patients With Pulmonary Hypertension

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2022 Feb 28

PMID 35223898

Authors

Arcangelo F Carta

Mona Lichtblau

Charlotte Berlier

Stephanie Saxer

Simon R Schneider

Esther I Schwarz

Michael Furian

Konrad E Bloch

Silvia Ulrich

Affiliations

Soon will be listed here.

Abstract

Background: Pure oxygen breathing (hyperoxia) may improve hemodynamics in patients with pulmonary hypertension (PH) and allows to calculate right-to-left shunt fraction (Qs/Qt), whereas breathing normobaric hypoxia may accelerate hypoxic pulmonary vasoconstriction (HPV). This study investigates how hyperoxia and hypoxia affect mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR) in patients with PH and whether Qs/Qt influences the changes of mPAP and PVR.

Study Design And Methods: Adults with pulmonary arterial or chronic thromboembolic PH (PAH/CTEPH) underwent repetitive hemodynamic and blood gas measurements during right heart catheterization (RHC) under normoxia [fractions of inspiratory oxygen (FiO) 0.21], hypoxia (FiO 0.15), and hyperoxia (FiO 1.0) for at least 10 min.

Results: We included 149 patients (79/70 PAH/CTEPH, 59% women, mean ± SD 60 ± 17 years). Multivariable regressions (mean change, ) showed that hypoxia did not affect mPAP and cardiac index, but increased PVR [0.4 (0.1-0.7) WU, = 0.021] due to decreased pulmonary artery wedge pressure [-0.54 (-0.92 to -0.162), = 0.005]. Hyperoxia significantly decreased mPAP [-4.4 (-5.5 to -3.3) mmHg, < 0.001] and PVR [-0.4 (-0.7 to -0.1) WU, = 0.006] compared with normoxia. The Qs/Qt (14 ± 6%) was >10 in 75% of subjects but changes of mPAP and PVR under hyperoxia and hypoxia were independent of Qs/Qt.

Conclusion: Acute exposure to hypoxia did not relevantly alter pulmonary hemodynamics indicating a blunted HPV-response in PH. In contrast, hyperoxia remarkably reduced mPAP and PVR, indicating a preserved vasodilator response to oxygen and possibly supporting the oxygen therapy in patients with PH. A high proportion of patients with PH showed increased Qs/Qt, which, however, was not associated with changes in pulmonary hemodynamics in response to changes in FiO.

Citing Articles

The acute effect of high-dose supplemental oxygen on haemodynamics assessed by echocardiography in patients with pulmonary vascular disease living in Quito at 2850 m: a randomized, single-blind, placebo-controlled crossover trial.

Muller J, Lichtblau M, Saxer S, Schmucki M, Furian M, Schneider S Eur Heart J Open. 2024; 4(6):oeae097.

PMID: 39698150 PMC: 11653896. DOI: 10.1093/ehjopen/oeae097.

Effects of acetazolamide on sleep disordered breathing in pulmonary vascular disease: a randomised controlled trial.

Schwarz E, Saxer S, Lichtblau M, Schneider S, Muller J, Mayer L ERJ Open Res. 2024; 10(5).

PMID: 39469274 PMC: 11514193. DOI: 10.1183/23120541.00040-2024.

Heart rate variability in pulmonary vascular disease at altitude: a randomised trial.

Herzig J, Ulrich S, Schneider S, Muller J, Lichtblau M, Ulrich T ERJ Open Res. 2024; 10(5).

PMID: 39469267 PMC: 11514194. DOI: 10.1183/23120541.00235-2024.

Long-term oxygen therapy in precapillary pulmonary hypertension - SOPHA study.

Benjamin N, Echampati I, Harutyunova S, Eichstaedt C, Egenlauf B, Ulrich S Sci Rep. 2024; 14(1):22038.

PMID: 39327434 PMC: 11427660. DOI: 10.1038/s41598-024-70650-w.

Effects of Dexmedetomidine in Improving Oxygenation and Reducing Pulmonary Shunt in High-Risk Pediatric Patients Undergoing One-Lung Ventilation for Thoracic Surgery: A Double-Blind Randomized Controlled Trial.

Khddam A, Rostom F, Hajeer M Cureus. 2024; 16(9):e69659.

PMID: 39296923 PMC: 11410298. DOI: 10.7759/cureus.69659.

References

Dunham-Snary K, Wu D, Sykes E, Thakrar A, Parlow L, Mewburn J . Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine. Chest. 2016; 151(1):181-192. PMC: 5310129. DOI: 10.1016/j.chest.2016.09.001. View

Ghofrani H, Voswinckel R, Reichenberger F, Weissmann N, Schermuly R, Seeger W . Hypoxia- and non-hypoxia-related pulmonary hypertension - established and new therapies. Cardiovasc Res. 2006; 72(1):30-40. DOI: 10.1016/j.cardiores.2006.07.025. View

Galie N, Humbert M, Vachiery J, Gibbs S, Lang I, Torbicki A . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):.... Eur Heart J. 2015; 37(1):67-119. DOI: 10.1093/eurheartj/ehv317. View

Green S, Stuart D . Oxygen and pulmonary arterial hypertension: effects, mechanisms, and therapeutic benefits. Eur J Prev Cardiol. 2021; 28(1):127-136. DOI: 10.1093/eurjpc/zwaa001. View

Maron B, Brittain E, Hess E, Waldo S, Baron A, Huang S . Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study. Lancet Respir Med. 2020; 8(9):873-884. PMC: 8219057. DOI: 10.1016/S2213-2600(20)30317-9. View

Humbert M . Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur Respir Rev. 2010; 19(115):59-63. PMC: 9491634. DOI: 10.1183/09059180.00007309. View

Ghofrani H, Galie N, Grimminger F, Grunig E, Humbert M, Jing Z . Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med. 2013; 369(4):330-40. DOI: 10.1056/NEJMoa1209655. View

Sharan L, Stackhouse K, Awerbach J, Bashore T, Krasuski R . Effect of Patent Foramen Ovale in Patients With Pulmonary Hypertension. Am J Cardiol. 2018; 122(3):505-510. DOI: 10.1016/j.amjcard.2018.04.014. View

Hagen P, Scholz D, Edwards W . Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984; 59(1):17-20. DOI: 10.1016/s0025-6196(12)60336-x. View

10.

Leuchte H, Baezner C, Baumgartner R, Mernitz P, Neurohr C, Behr J . Acute hemodynamic responses to supplemental oxygen and their prognostic implications in pulmonary hypertension. Respiration. 2012; 85(5):400-7. DOI: 10.1159/000340009. View

11.

Maggiorini M, Leon-Velarde F . High-altitude pulmonary hypertension: a pathophysiological entity to different diseases. Eur Respir J. 2003; 22(6):1019-25. DOI: 10.1183/09031936.03.00052403. View

12.

Lang I, Dorfmuller P, Vonk Noordegraaf A . The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension. Ann Am Thorac Soc. 2016; 13 Suppl 3:S215-21. DOI: 10.1513/AnnalsATS.201509-620AS. View

13.

Sylvester J, Shimoda L, Aaronson P, Ward J . Hypoxic pulmonary vasoconstriction. Physiol Rev. 2012; 92(1):367-520. PMC: 9469196. DOI: 10.1152/physrev.00041.2010. View

14.

Nootens M, Berarducci L, Kaufmann E, DeVries S, Rich S . The prevalence and significance of a patent foramen ovale in pulmonary hypertension. Chest. 1993; 104(6):1673-5. DOI: 10.1378/chest.104.6.1673. View

15.

Hasler E, Muller-Mottet S, Furian M, Saxer S, Huber L, Maggiorini M . Pressure-Flow During Exercise Catheterization Predicts Survival in Pulmonary Hypertension. Chest. 2016; 150(1):57-67. DOI: 10.1016/j.chest.2016.02.634. View

16.

Simonneau G, Montani D, Celermajer D, Denton C, Gatzoulis M, Krowka M . Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2018; 53(1). PMC: 6351336. DOI: 10.1183/13993003.01913-2018. View

17.

Milger K, Felix J, Voswinckel R, Sommer N, Franco O, Grimminger F . Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension. Pulm Circ. 2015; 5(2):305-12. PMC: 4449241. DOI: 10.1086/680355. View

18.

Xanthouli P, Jordan S, Milde N, Marra A, Blank N, Egenlauf B . Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension. Ann Rheum Dis. 2019; 79(3):370-378. DOI: 10.1136/annrheumdis-2019-216476. View

19.

Kovacs G, Avian A, Pienn M, Naeije R, Olschewski H . Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med. 2014; 190(3):252-7. DOI: 10.1164/rccm.201402-0269PP. View

20.

Groth A, Saxer S, Bader P, Lichtblau M, Furian M, Schneider S . Acute hemodynamic changes by breathing hypoxic and hyperoxic gas mixtures in pulmonary arterial and chronic thromboembolic pulmonary hypertension. Int J Cardiol. 2018; 270:262-267. DOI: 10.1016/j.ijcard.2018.05.127. View